AI in autonomous telemedicine
- 13:00 22nd February 2022 ( week 6, Hilary Term 2022 )LTA - Wolfson building Oxford - Also live streamed
Healthcare services are in crisis - ageing population, constrained resources and now, the COVID-19 pandemic. In the UK alone, 6M people are on waiting lists, with worst-case predictions indicating this could soon exceed 10M, 30% of the doctors are facing burnout and the Government has just announced further delays. There is clearly a need for innovative solutions to this crisis.
Ufonia is tackling this challenge with its pioneering CE-marked AI-driven conversational voice agent Dora. Dora talks to the patients on behalf of a clinician to perform routine appointments. This allows patients to receive reliable high-quality care quicker, and allows clinicians to spend their time helping the patients who need it the most. Having already completed multiple clinical trials to show the safety, efficacy and acceptability of Dora, Ufonia is transforming the way healthcare is delivered with an evidence-driven and clinically safe approach.
Mohita talks about working in Ufonia and how state-of-the-art AI is being used in the highly regulated Healthcare Industry to address the current challenges.
This talk will be held in-person in LTA (Wolfson Building) although, if you are unable to attend in person we will live stream via the following Teams link
Microsoft Teams meeting
Join on your computer or mobile app
Speaker bio
Mohita Chowdhury completed her MSc in Computer Science from Oxford in 2020. During her time at Oxford, she focused on Artificial Intelligence and worked with Prof Phil Blunsom and the Visual Geometry Group (VGG), exploring the intersection between Natural Language and Vision. She received her Bachelor's degree in Electronics and Communication Engineering from NIT Karnataka, India and has extensive research experience at leading AI labs around the world.Currently, Mohita works as an AI Research Engineer at Ufonia, an Oxford University spinout addressing challenges in healthcare using autonomous telemedicine and AI.
Share this:
